Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 3892Healthcare 878Financial Services 629Technology 560Industrials 517Consumer Cyclical 330Basic Materials 232Energy 196Communication Services 168Real Estate 161Consumer Defensive 134Utilities 87
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRVIMaravai LifeSciences Holdings, Inc. | Healthcare | Nov 4 | Sep '26 | $46.0M | +9.5% | −$14.0M | n/m | −$0.09 | n/m | -45.0% | −322.3 pp | $2.1B |
| VCYTVeracyte, Inc. | Healthcare | Nov 4 | Sep '26 | $152M | +15.2% | $32.0M | +68.4% | $0.38 | +58.3% | 10.9% | −6.5 pp | $2.0B |
| HRMYHarmony Biosciences Holdings, Inc. | Healthcare | Nov 4 | Sep '26 | $269M | +12.6% | $48.0M | −5.9% | $0.81 | −6.9% | 20.1% | −7.2 pp | $1.9B |
| AGLagilon health, inc. | Healthcare | Nov 4 | Sep '26 | $1.52B | +5.9% | $35.0M | n/m | $1.97 | n/m | 1.6% | +10.7 pp | $1.9B |
| BCRXBioCryst Pharmaceuticals, Inc. | Healthcare | Nov 4 | Sep '26 | $180M | +13.2% | $38.0M | +192.3% | $0.14 | +133.3% | 29.6% | +11.0 pp | $1.9B |
| LMATLeMaitre Vascular, Inc. | Healthcare | Nov 4 | Sep '26 | $68.0M | +11.5% | $15.0M | −11.8% | $0.65 | −13.3% | 26.0% | −7.2 pp | $1.7B |
| PSNLPersonalis, Inc. | Healthcare | Nov 4 | Sep '26 | $26.0M | +85.7% | −$34.0M | n/m | −$0.32 | n/m | -138.8% | +21.9 pp | $1.6B |
| VIRVir Biotechnology, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$96.0M | n/m | −$0.57 | n/m | — | — | $1.6B |
| KLRAKailera Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | — | −$96.0M | — | −$0.74 | — | — | — | $1.6B |
| PGENPrecigen, Inc. | Healthcare | Nov 4 | Sep '26 | $74.0M | +2,367% | $36.0M | n/m | $0.08 | n/m | 52.1% | — | $1.5B |
| URGNUroGen Pharma Ltd. | Healthcare | Nov 4 | Sep '26 | $89.0M | +229.6% | −$1.0M | n/m | −$0.03 | n/m | 9.4% | +109.0 pp | $1.5B |
| QUREuniQure N.V. | Healthcare | Nov 4 | Sep '26 | $5.0M | +25.0% | −$61.0M | n/m | −$0.88 | n/m | — | — | $1.5B |
| USPHU.S. Physical Therapy, Inc. | Healthcare | Nov 4 | Sep '26 | $223M | +36.0% | $11.0M | +57.1% | −$1.04 | −316.7% | 11.3% | −4.2 pp | $1.5B |
| PAHCPhibro Animal Health Corporation | Healthcare | Nov 4 | Sep '26 | $387M | +6.3% | $30.0M | +11.1% | $0.72 | +10.8% | 12.8% | −0.3 pp | $1.4B |
| DMRADamora Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$32.0M | n/m | −$0.40 | n/m | — | — | $1.4B |
| NUVBNuvation Bio Inc. | Healthcare | Nov 4 | Sep '26 | $45.0M | +246.2% | −$42.0M | n/m | −$0.12 | n/m | -93.9% | +336.2 pp | $1.4B |
| PRCTPROCEPT BioRobotics Corporation | Healthcare | Nov 4 | Sep '26 | $98.0M | +18.1% | −$27.0M | n/m | −$0.46 | n/m | -27.9% | −0.0 pp | $1.4B |
| INVAInnoviva, Inc. | Healthcare | Nov 4 | Sep '26 | $106M | −1.9% | −$74.0M | −182.2% | −$1.03 | −195.4% | 39.7% | +7.6 pp | $1.3B |
| STAASTAAR Surgical Company | Healthcare | Nov 4 | Sep '26 | $83.0M | −12.6% | $6.0M | −33.3% | $0.11 | −38.9% | 6.5% | −13.0 pp | $1.3B |
| PNTGThe Pennant Group, Inc. | Healthcare | Nov 4 | Sep '26 | $302M | +31.9% | $10.0M | +66.7% | $0.26 | +52.9% | 5.5% | +1.0 pp | $1.3B |
| MLYSMineralys Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$57.0M | n/m | −$0.64 | n/m | — | — | $1.3B |
| OPKOpko Health, Inc. | Healthcare | Nov 4 | Sep '26 | $65.0M | n/m | −$54.0M | n/m | −$0.07 | n/m | -48.0% | — | $1.2B |
| RAPPRapport Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$40.0M | n/m | −$0.84 | n/m | — | — | $1.1B |
| MLTXMoonLake Immunotherapeutics | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$80.0M | n/m | −$0.93 | n/m | — | — | $957M |
| ODTXOdyssey Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | — | −$53.0M | — | −$1.11 | — | — | — | $931M |
| CTKBCytek Biosciences, Inc. | Healthcare | Nov 4 | Sep '26 | $53.0M | +1.9% | −$6.0M | n/m | −$0.05 | n/m | -15.8% | +1.8 pp | $745M |
| SLDBSolid Biosciences Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$54.0M | n/m | −$0.36 | n/m | — | — | $695M |
| NVCTNuvectis Pharma, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$30.0M | n/m | −$1.02 | n/m | — | — | $660M |
| GERNGeron Corporation | Healthcare | Nov 4 | Sep '26 | $60.0M | +27.7% | $1.0M | n/m | $0.00 | n/m | 9.5% | +38.9 pp | $644M |
| DSGNDesign Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$20.0M | n/m | −$0.32 | n/m | — | — | $630M |
| SGHTSight Sciences, Inc. | Healthcare | Nov 4 | Sep '26 | $25.0M | +25.0% | −$7.0M | n/m | −$0.12 | n/m | -24.6% | +15.1 pp | $583M |
| PACBPacific Biosciences of California, Inc. | Healthcare | Nov 4 | Sep '26 | $41.0M | +7.9% | −$38.0M | n/m | −$0.12 | n/m | -91.2% | +9.7 pp | $568M |
| MYGNMyriad Genetics, Inc. | Healthcare | Nov 4 | Sep '26 | $203M | −1.5% | −$44.0M | n/m | −$0.46 | n/m | -19.7% | −8.3 pp | $531M |
| TKNOAlpha Teknova, Inc. | Healthcare | Nov 4 | Sep '26 | $13.0M | +30.0% | −$3.0M | n/m | −$0.06 | n/m | -25.2% | +13.2 pp | $481M |
| EOLSEvolus, Inc. | Healthcare | Nov 4 | Sep '26 | $77.0M | +11.6% | −$13.0M | n/m | −$0.19 | n/m | -10.9% | +5.8 pp | $443M |
| VMDViemed Healthcare, Inc. | Healthcare | Nov 4 | Sep '26 | $81.0M | +12.5% | $5.0M | +25.0% | $0.11 | +22.2% | 8.6% | +0.1 pp | $344M |
| LYELLyell Immunopharma, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$46.0M | n/m | −$1.86 | n/m | — | — | $336M |
| QTTBQ32 Bio Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$9.0M | n/m | −$0.26 | n/m | — | — | $258M |
| OCGNOcugen, Inc. | Healthcare | Nov 4 | Sep '26 | $2.0M | 0.0% | −$4.0M | n/m | −$0.01 | n/m | -909.9% | — | $257M |
| LFCRLifecore Biomedical, Inc. | Healthcare | Nov 4 | Sep '26pending | $25.3M† | −18.3% | — | — | — | — | — | — | $242M |
| ACIUAC Immune SA | Healthcare | Nov 4 | Sep '26 | $3.9M | +200.0% | — | n/m | −$0.16 | n/m | -302.1% | — | $215M |
| NAGENiagen Bioscience, Inc. | Healthcare | Nov 4 | Sep '26 | $27.0M | −20.6% | −$1.0M | −120.0% | −$0.01 | −120.0% | -5.8% | −18.3 pp | $162M |
| OKUROnKure Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | −$18.0M | n/m | −$0.36 | n/m | — | — | $104M |
| STIMNeuronetics, Inc. | Healthcare | Nov 4 | Sep '26pending | $42.0M† | +13.4% | — | — | — | — | — | — | $99M |
| SERASera Prognostics, Inc. | Healthcare | Nov 4 | Sep '26pending | $0.0M† | n/m | — | — | — | — | — | — | $78M |
| TNYATenaya Therapeutics, Inc. | Healthcare | Nov 4 | Sep '26pending | $1.7M† | n/m | — | — | — | — | — | — | $74M |
| GEGGreat Elm Group, Inc. | Healthcare | Nov 4 | Sep '26pending | $3.3M† | −69.7% | — | — | — | — | — | — | $66M |
| OMOutset Medical, Inc. | Healthcare | Nov 4 | Sep '26pending | $33.6M† | +15.9% | — | — | — | — | — | — | $60M |
| CLNNClene Inc. | Healthcare | Nov 4 | Sep '26 | $0.0M | n/m | $4.0M | n/m | $0.05 | n/m | — | — | $46M |
| ECORelectroCore, Inc. | Healthcare | Nov 4 | Sep '26 | $10.0M | +11.1% | −$1.0M | n/m | −$0.13 | n/m | -16.1% | +17.1 pp | $44M |
- Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.